LAKE
Who is this for?
Those with refractory or unexplained chronic cough (cough ≥ 8 weeks)
Study:
This clinical trial evaluats the efficacy and safety of extended-release nalbuphine tablets in adults with refractory chronic cough.
Those with refractory or unexplained chronic cough (cough ≥ 8 weeks)
This clinical trial evaluats the efficacy and safety of extended-release nalbuphine tablets in adults with refractory chronic cough.